Close

Monthly Archives: August, 2017

Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities

Merck, a leading science and technology company, today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider...

University of Washington researchers developed New app uses smartphone selfies to screen for pancreatic cancer

Pancreatic cancer has one of the worst prognoses  with a five-year survival rate of 9 percent in part because there are no telltale symptoms...

Through TMG Health acquisition, Cognizant Solidifies Position as Top Service Provider for Government Managed Healthcare Programs in U.S

Cognizant announced it has completed its acquisition of TMG Health, a leading national provider of business process services to the Medicare Advantage, Medicare Part...

Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)

Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results...

Cancer Research UK launches trial to test new drug in patients with advanced cancer

A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres* across the UK, through Cancer...

PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms

PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to...

Psychological Impact on Pediatric Cancer Patients

Cancer is considered as the most deadly disease and is indeed a slow killer. The impact that cancer has not only on the patient...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read